ATC code H05

ATC code H05 Calcium homeostasis is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2] Subgroup H05 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[3]

ATC codes
H Systemic hormonal preparations, excluding sex hormones and insulins
H01 Pituitary and hypothalamic hormones and analogues
H02 Corticosteroids for systemic use
H03 Thyroid therapy
H04 Pancreatic hormones
H05 Calcium homeostasis

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH05.[4]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

H05A Parathyroid hormones and analogues

H05AA Parathyroid hormones and analogues

H05AA01 Parathyroid gland extract

H05AA02 Teriparatide

H05AA03 Parathyroid hormone

H05AA04 Abaloparatide

H05B Anti-parathyroid agents

H05BA Calcitonin preparations

H05BA01 Calcitonin (salmon synthetic)

H05BA02 Calcitonin (pork natural)

H05BA03 Calcitonin (human synthetic)

H05BA04 Elcatonin

H05BX Other anti-parathyroid agents

H05BX01 Cinacalcet

H05BX02 Paricalcitol

H05BX03 Doxercalciferol

H05BX04 Etelcalcetide

H05BX05 Calcifediol

References

1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 2020-02-01.
2. "ATC-Klassifikation mit definierten Tagesdosen DDD" (in German). German Institute for Medical Documentation and Information. Retrieved 2020-02-01.
3. "ATC/DDD Index 2021: code H05". WHO Collaborating Centre for Drug Statistics Methodology.
4. "ATCvet Index 2021: code QH05". WHO Collaborating Centre for Drug Statistics Methodology.